Atlas Trials

Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).

Clinical trial NCT00741325 · COMPLETED

Trial details

NCT number
NCT00741325
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Study type
OBSERVATIONAL
Non-Hodgkin's LymphomaAutologous Transplantation
Start date
2006-06-01
Primary completion
2011-11-01
Enrollment
178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.